Lunit

Lunit Net Debt

The Net Debt of Lunit (328130.KQ) as of Oct 16, 2026 is 6.59 B KRW. In the previous year, Net Debt was 4.15 B KRW — a change of 58.90% (higher).

Net Debt

6.59 BKRW

YoY

58.90%

Last updated:

Net Debt of Lunit is 2024 6.59 B KRW. Net Debt of Lunit was 2023 4.15 B KRW. It decreases by 58.90% higher compared to the previous year.

The Lunit Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2019
-36.57 B KRW
Jan 1, 2020
11.33 B KRW
Jan 1, 2021
-85.78 B KRW
Jan 1, 2022
-1.13 B KRW
Jan 1, 2023
4.15 B KRW
Jan 1, 2024
6.59 B KRW
The Lunit Net Debt history
YEARNet DebtYoY
6.59 BKRW+58.90%
4.15 BKRW-466.02%
-1.13 BKRW-98.68%
-85.78 BKRW-856.80%
11.33 BKRW-131.00%
-36.57 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Lunit Stock analysis

What does Lunit do? Lunit Inc is a South Korean company headquartered in Seoul, operating within the Health Care sector. The company has 293 employees and went public on July 21, 2022, with its ticker listed as 328130.KQ and ISIN KR7328130000. Lunit provides software solutions for medical diagnostic imaging services, focusing on the development and supply of AI-powered medical software. Its offerings include cancer diagnostic aid solutions, cancer early detection solutions, and cancer risk prediction solutions. The company's technology leverages artificial intelligence to enhance diagnostic capabilities in healthcare settings. Lunit's website is www.lunit.io, where further information about its services and solutions can be accessed. The company operates in the Health Care industry, specifically targeting medical imaging and AI-driven diagnostic tools. As of the latest available data, Lunit is engaged in the development and commercialization of AI-based medical software, aiming to improve the accuracy and efficiency of cancer-related diagnostics. The firm's IPO date marks its transition to a publicly traded company, reflecting its growth and market position in the healthcare technology space. Lunit's focus on AI applications in medical imaging positions it as a key player in the digital health sector, particularly within the Korean market and beyond. The company's solutions are designed to support healthcare professionals in making more informed diagnostic decisions, potentially reducing the time and resources required for cancer detection and treatment planning. Lunit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lunit stock

Net Debt of Lunit is 6.59 B KRW in 2024.

Net Debt of Lunit changed from 4.15 B KRW to 6.59 B KRW, representing a 58.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt Lunit since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's Lunit historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Lunit

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Lunit